The forward P/E compression from 19.5x to 19.0x is minimal, underscoring limited market expectations for earnings acceleration; this makes GTY a borderline fair‑value play unless upcoming lease renewals or asset acquisitions boost cash flow.
The PEG ratio of 1.5x signals that price growth may outpace earnings expansion by roughly 50%; if GTY fails to deliver its projected earnings trajectory, the stock could experience a valuation correction of up to 10% relative to peers.
| Metric | Historical DCF | Analyst DCF |
|---|---|---|
| Growth Assumption | 9.0% (10Y CAGR) | Analyst Rev × 57.9% margin |
| PV of FCF | $689.5M | $684.3M |
| Terminal Value (PV) | $3.63B | $3.21B |
| Enterprise Value | $4.32B | $3.89B |
| Equity Value | $3.28B | $2.85B |
| Implied Stock Price | $58.25 | $50.56 |
| Upside/Downside | +80.8% | +56.9% |
| WACC \ Growth | 1.0% | 1.5% | 2.0% | 2.5% | 3.0% |
|---|---|---|---|---|---|
| 4.1% | $87 | $105 | $132 | $176 | $260 |
| 5.1% | $61 | $70 | $83 | $101 | $127 |
| 6.1% | $45 | $51 | $58 | $67 | $79 |
| 7.1% | $34 | $38 | $43 | $48 | $55 |
| 8.1% | $26 | $29 | $32 | $36 | $41 |
| WACC \ Growth | 1.0% | 1.5% | 2.0% | 2.5% | 3.0% |
|---|---|---|---|---|---|
| 4.1% | $76 | $92 | $116 | $155 | $229 |
| 5.1% | $53 | $61 | $73 | $88 | $111 |
| 6.1% | $39 | $44 | $50 | $58 | $69 |
| 7.1% | $29 | $33 | $37 | $42 | $48 |
| 8.1% | $22 | $25 | $28 | $31 | $35 |
| Method | Implied Value | Upside/Downside | Basis |
|---|---|---|---|
| P/E (Peer) | $24.59 | -23.7% | Peer median P/E (14.5x) × Forward EPS ($1.70) |
| P/B (Peer) | $19.87 | -38.3% | Peer median P/B (0.89x) × Book Value per Share |
| EV/EBITDA (Peer) | $29.45 | -8.6% | Peer median EV/EBITDA (14.4x) × EBITDA - Net Debt |
| P/S (Peer) | $15.12 | -53.1% | Peer median P/S (3.26x) × Revenue per Share |
| DCF | $58.25 | +80.8% | Revenue × FCF Margin projection |
| Analyst Target | $34.50 | +7.1% | Consensus of 1 analysts |
This report is generated by Finexus and is provided for informational purposes only. It does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any security.
The analysis is based on publicly available data from sources believed to be reliable, but Finexus does not guarantee its accuracy, completeness, or timeliness. Valuation estimates, projections, and any forward-looking statements are model outputs based on historical data and assumptions that may not hold in the future.
Past performance is not indicative of future results. Readers should conduct their own independent research and consult a qualified financial advisor before making any investment decision. Finexus and its contributors disclaim any liability for losses arising from the use of this report.
Created 2026-06-07 · finexus.net